|

BEBT-109 Capsule Clinical Trials

1 actively recruiting trial

Also known as: KCBT-1083

Pipeline

Phase 2: 1

Top Sponsors

  • BeBetter Med Inc1

Indications

  • EGFR Exon 20 Insertion Mutation1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Other1 trial

Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.